BioTime

BioTime

BioTime

BioTime, a biotechnology company, is engaged in biomedical R&D in regenerative medicine and stem cell therapeutics.
Founded
1992
Raised
$52.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$2,000,000
Grant - 2017
$10,550,000
Post-IPO equity - 2016
Team Size
50+
Employees
FinSMEs

Biotechnology Company BioTime to Receive $43M From Juvenescence

Health Funding
$2,000,000 Grant
businesswire

BioTime Announces $2 Million Grant for Further Development of OpRegen® for Dry-AMD

$2,200,000 Grant
businesswire

BioTime Announces $2.2 Million Grant for Further Development of Dry-AMD Program | Business Wire